ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2026
NEMO (IKKγ) citrullination in microglia promotes neuroinflammation in the post-ischemic brain.
Article in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peptidylarginine deiminase (PAD) catalyzes the post-translational conversion of positively charged arginine residues into neutral citrulline. This modification, known as citrullination, is implicated in various pathological conditions, including those affecting the central nervous system. This study investigated the pro-inflammatory role of PAD in microglia using a middle cerebral artery occlusion (MCAO) animal model of ischemic stroke. Pharmacological inhibition of PAD via BB-Cl-amidine (BBCA; a pan-PAD inhibitor) exerted robust anti-inflammatory and neuroprotective effects in the post-ischemic brain in a broad therapeutic window. A significant accumulation of citrullinated proteins was detected in activated microglia following ischemia, which was suppressed by BBCA. Notably, we demonstrate that citrullination of NEMO (IKKγ), a key regulator that activates the NF-κB signaling pathway, was significantly induced in the post-ischemic brain, facilitating NEMO-IKKα/IKKβ assembly. Importantly, BBCA inhibited NEMO citrullination and disrupted subsequent IKK assembly, highlighting the critical role of PAD in this process. Targeted knockdown experiments using siRNA in BV2 microglial cells revealed that both PAD2 and PAD4 play crucial role in NEMO citrullination and NF-κB-mediated pro-inflammatory response. Furthermore, inhibiting NEMO citrullination with a NEMO-binding domain peptide (NBDp) or co-treatment with NBDp and BBCA, further supports a crucial role for PAD-mediated NEMO citrullination in post-ischemic neuroinflammation. Collectively, these results suggest that PAD2 and PAD4 drive pro-inflammatory processes following cerebral ischemia by upregulating NEMO citrullination and subsequent IKK complex formation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.